Position in COGT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$202,149
New position
Shares Held
5,252
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $12,717,475 across 25 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,230 | $2,101,167 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,732 | $1,703,511 | |
| 3 | ARGX |
Argenx SE
|
1,311 | $1,216,306 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,952 | $1,048,126 | |
| 5 | INSM |
INSMED Inc
|
7,262 | $774,274 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
17,281 | $644,062 | |
| 7 | QURE |
uniQure N.V.
|
10,874 | $500,856 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,583 | $422,217 |
All Filings in COGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $202,149 | 5,252 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||